Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of FLUAD Influenza Vaccine (2005–2006 Formulation) in Elderly Subjects
2005-000621-38Phase 2Completed
- Sponsor
- Chiron Corporation
- Start
- Aug 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Fluzone Trivalent in influenza, sponsored by Chiron Corporation. Primary endpoint: CPMP criteria response for influenza vaccines. Started Aug 2007; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on 2005-000621-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000621-38.